Author

Aysegül Aksan

IN CONTRAST TO ORAL IRON THERAPY, INTRAVENOUS IRON THERAPY IS NEITHER INFLUENCED BY, NOR DOES IT EXACERBATE, SYSTEMIC INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
IN CONTRAST TO ORAL IRON THERAPY, INTRAVENOUS IRON THERAPY IS NEITHER INFLUENCED BY, NOR DOES IT EXACERBATE, SYSTEMIC INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Aysegül Aksan  et al.

DETECTION OF IRON RESTRICTED ERYTHROPOIESIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OVERCOMING THE INFLAMMATION TANGLER
DETECTION OF IRON RESTRICTED ERYTHROPOIESIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OVERCOMING THE INFLAMMATION TANGLER

Aysegül Aksan  et al.

EXPLORING HYPOPHOSPHATAEMIA: HOW FREQUENTLY DOES IT OCCUR IN INFLAMMATORY BOWEL DISEASE AND WHAT ARE THE IMPLICATIONS FOR INTRAVENOUS IRON THERAPY?
EXPLORING HYPOPHOSPHATAEMIA: HOW FREQUENTLY DOES IT OCCUR IN INFLAMMATORY BOWEL DISEASE AND WHAT ARE THE IMPLICATIONS FOR INTRAVENOUS IRON THERAPY?

Aysegül Aksan  et al.

EFFECT OF VITAMIN D SUPPLEMENTATION ON VITAMIN D, ITS METABOLITES AND VITAMIN D BINDING PROTEIN IN INFLAMMATORY BOWEL DISEASE: DOES INFLAMMATION MATTER?
EFFECT OF VITAMIN D SUPPLEMENTATION ON VITAMIN D, ITS METABOLITES AND VITAMIN D BINDING PROTEIN IN INFLAMMATORY BOWEL DISEASE: DOES INFLAMMATION MATTER?

Aysegül Aksan  et al.

HYPOPHOSPHATAEMIA PRIOR TO INTRAVENOUS IRON TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: IS IT MORE COMMON THAN IN THE GENERAL POPULATION?
HYPOPHOSPHATAEMIA PRIOR TO INTRAVENOUS IRON TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: IS IT MORE COMMON THAN IN THE GENERAL POPULATION?

Aysegül Aksan  et al.

IN CONTRAST TO ORAL IRON THERAPY, INTRAVENOUS IRON THERAPY IS NEITHER INFLUENCED BY, NOR DOES IT EXACERBATE, SYSTEMIC INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
IN CONTRAST TO ORAL IRON THERAPY, INTRAVENOUS IRON THERAPY IS NEITHER INFLUENCED BY, NOR DOES IT EXACERBATE, SYSTEMIC INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

SENSITIVITY AND SPECIFICITY OF DIFFERENT PARAMETERS FOR THE DIAGNOSIS AND DIFFERENTIATION OF IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE
SENSITIVITY AND SPECIFICITY OF DIFFERENT PARAMETERS FOR THE DIAGNOSIS AND DIFFERENTIATION OF IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE

IS VITAMIN D DEFICIENCY RELATED TO FAT MALABSORPTION OR INFLAMMATION IN INFLAMMATORY BOWEL DISEASE? PRELIMINARY RESULTS FROM THE FAT-D STUDY
IS VITAMIN D DEFICIENCY RELATED TO FAT MALABSORPTION OR INFLAMMATION IN INFLAMMATORY BOWEL DISEASE? PRELIMINARY RESULTS FROM THE FAT-D STUDY

DETECTION OF IRON RESTRICTED ERYTHROPOIESIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OVERCOMING THE INFLAMMATION TANGLER
DETECTION OF IRON RESTRICTED ERYTHROPOIESIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OVERCOMING THE INFLAMMATION TANGLER

DOES BIOTIN DEFICIENCY PLAY A ROLE IN IBD PATHOGENESIS? PRELIMINARY RESULTS OF A CROSS-SECTIONAL STUDY
DOES BIOTIN DEFICIENCY PLAY A ROLE IN IBD PATHOGENESIS? PRELIMINARY RESULTS OF A CROSS-SECTIONAL STUDY

SENSITIVITY AND SPECIFICITY OF DIFFERENT PARAMETERS FOR THE DIAGNOSIS AND DIFFERENTIATION OF IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE
SENSITIVITY AND SPECIFICITY OF DIFFERENT PARAMETERS FOR THE DIAGNOSIS AND DIFFERENTIATION OF IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE

Aysegül Aksan  et al.

USE OF HAEMATOLOGICAL IRON PARAMETERS ALONE OR IN COMBINATION TO DETECT IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE
USE OF HAEMATOLOGICAL IRON PARAMETERS ALONE OR IN COMBINATION TO DETECT IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE

ASSOCIATION BETWEEN SERUM VITAMIN D METABOLITES AND HEMATOLOGICAL MARKERS OF INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ASSOCIATION BETWEEN SERUM VITAMIN D METABOLITES AND HEMATOLOGICAL MARKERS OF INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

ASSOCIATION OF SERUM VITAMIN D LEVELS WITH DRUG TROUGH CONCENTRATIONS AND ANTI-DRUG ANTIBODY LEVELS DURING INFLIXIMAB THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ASSOCIATION OF SERUM VITAMIN D LEVELS WITH DRUG TROUGH CONCENTRATIONS AND ANTI-DRUG ANTIBODY LEVELS DURING INFLIXIMAB THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

TO “D” OR NOT TO “D”: IS INACCURATE TESTING CAUSING OUR VITAMIN D SUPPLEMENTATION TO BE OFF THE MARK? - LESSONS FROM INFLAMMATORY BOWEL DISEASE
TO “D” OR NOT TO “D”: IS INACCURATE TESTING CAUSING OUR VITAMIN D SUPPLEMENTATION TO BE OFF THE MARK? - LESSONS FROM INFLAMMATORY BOWEL DISEASE

Aysegül Aksan  et al.

IN CONTRAST TO FAECAL CALPROTECTIN (FC), INCREASED FAECAL APHA-1-ANTITRYPSIN (A1AT) EXCRETION IS ASSOCIATED WITH LOW THROUGH LEVELS IN PATIENTS WITH SEVERE ULCERATIVE COLITIS LACKING RESPONSE TO MONOCLONAL ANTIBODY (MAB) THERAPY
IN CONTRAST TO FAECAL CALPROTECTIN (FC), INCREASED FAECAL APHA-1-ANTITRYPSIN (A1AT) EXCRETION IS ASSOCIATED WITH LOW THROUGH LEVELS IN PATIENTS WITH SEVERE ULCERATIVE COLITIS LACKING RESPONSE TO MONOCLONAL ANTIBODY (MAB) THERAPY

Aysegül Aksan  et al.

THE IMPACT OF THE DUODENOJEJUNAL BYPASS LINER ON IRON HOMEOSTASIS
THE IMPACT OF THE DUODENOJEJUNAL BYPASS LINER ON IRON HOMEOSTASIS

Aysegül Aksan  et al.

COMPARATIVE EFFICACY AND SAFETY OF DIFFERENT INTRAGASTRIC BALLOONS IN A REAL-WORLD POPULATION – A PROPENSITY SCORE MATCHING ANALYSIS
COMPARATIVE EFFICACY AND SAFETY OF DIFFERENT INTRAGASTRIC BALLOONS IN A REAL-WORLD POPULATION – A PROPENSITY SCORE MATCHING ANALYSIS

Aysegül Aksan  et al.

EFFICACY, SAFETY AND COST EFFECTIVENESS OF INTRAGASTRIC BALLOON THERAPY COMPARED TO A MULTIDISCIPLINARY WEIGHT LOSS PROGRAM IN A REAL-WORLD POPULATION – A PROPENSITY SCORE MATCHING ANALYSIS
EFFICACY, SAFETY AND COST EFFECTIVENESS OF INTRAGASTRIC BALLOON THERAPY COMPARED TO A MULTIDISCIPLINARY WEIGHT LOSS PROGRAM IN A REAL-WORLD POPULATION – A PROPENSITY SCORE MATCHING ANALYSIS

Aysegül Aksan  et al.

THE ROLE OF VITAMIN D STATUS ON EFFECTIVENESS OF BIOLOGIC THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
THE ROLE OF VITAMIN D STATUS ON EFFECTIVENESS OF BIOLOGIC THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Aysegül Aksan  et al.

Item 1 - 20 / 25
1
2